Heart Transplant Rejection
📧 Sign up to get email alerts when something new happens for Heart Transplant Rejection.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2026-03-18FDA Approved: MYCOPHENOLATE MOFETIL — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for mycophenolate mofetil from Aurobindo Pharma Limited under an ANDA.
-
FDA approval · 2026-02-23FDA Approved: MYCOPHENOLATE MOFETIL — Supplemental Application (Amneal Pharmaceuticals NY LLC)
The FDA approved Amneal Pharmaceuticals NY LLC's supplemental application for Mycophenolate mofetil (generic) under the ANDA, approving chan…
-
FDA approval · 2026-01-21FDA Approved: CYCLOSPORINE — Original Application (Upsher-Smith Laboratories, LLC)
FDA approved Upsher-Smith's original ANDA for generic cyclosporine.
-
FDA approval · 2025-10-17FDA Approved: TACROLIMUS — Supplemental Application (NORTHSTAR RX LLC)
The FDA approved a supplemental application for tacrolimus (generic) submitted by NORTHSTAR RX LLC.
-
FDA approval · 2025-09-26FDA Approved: TACROLIMUS — Supplemental Application (Biocon Pharma Inc.)
FDA approved Biocon Pharma Inc.'s supplemental application for tacrolimus, updating labeling to support its use in preventing organ transpla…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2025-06-27FDA Approved: MYHIBBIN — Supplemental Application (Azurity Pharmaceuticals, Inc.)
FDA approved a supplemental application for MYHIBBIN (mycophenolate mofetil) submitted by Azurity Pharmaceuticals, Inc. The supplement perta…
-
FDA approval · 2025-02-12FDA Approved: MYCOPHENOLATE MOFETIL — Supplemental Application (Strides Pharma Science Limited)
The FDA approved a supplemental application for mycophenolate mofetil from Strides Pharma Science Limited.
-
FDA approval · 2025-02-12FDA Approved: TACROLIMUS — Original Application (Nexus Pharmaceuticals, LLC)
Generic tacrolimus from Nexus Pharmaceuticals has been approved through an original ANDA for use in preventing organ transplant rejection.
-
FDA approval · 2024-11-07FDA Approved: MYCOPHENOLATE MOFETIL — Original Application (Wuxi Fortune Pharmaceutical Co.,Ltd.)
The FDA approved the original application for a generic mycophenolate mofetil formulation from Wuxi Fortune Pharmaceutical Co., Ltd.
-
FDA approval · 2024-10-22FDA Approved: MYCOPHENOLATE MOFETIL — Original Application (Camber Pharmaceuticals, Inc.)
FDA approves Camber Pharmaceuticals' original application for a generic mycophenolate mofetil product.
-
FDA approval · 2024-08-13FDA Approved: MYCOPHENOLATE MOFETIL — Supplemental Application (Accord Healthcare Inc.)
FDA approves Accord Healthcare's supplemental application for generic Mycophenolate mofetil. The approval supports continued use for prevent…
-
FDA approval · 2024-08-13FDA Approved: MYCOPHENOLATE MOFETIL — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for Mycophenolate mofetil from Aurobindo Pharma Limited, allowing the generic product for use in pre…
-
FDA approval · 2024-08-13FDA Approved: CELLCEPT — Supplemental Application (Genentech, Inc.)
The FDA approved a supplemental application for CellCept (mycophenolate mofetil hydrochloride) submitted by Genentech to update the label.
-
FDA approval · 2024-08-13FDA Approved: CELLCEPT — Supplemental Application (Genentech, Inc.)
The FDA approved a supplemental application for CellCept (mycophenolate mofetil) submitted by Genentech, Inc.
-
FDA approval · 2024-08-13FDA Approved: MYCOPHENOLATE MOFETIL — Supplemental Application (Meitheal Pharmaceuticals Inc.)
FDA approved a supplemental application for Mycophenolate mofetil from Meitheal Pharmaceuticals Inc., confirming the generic product's appro…
-
FDA approval · 2024-08-13FDA Approved: CELLCEPT — Supplemental Application (Genentech, Inc.)
FDA approved Genentech's supplemental application for CELLCEPT (mycophenolate mofetil), resulting in an approved update to the product label…
-
FDA approval · 2024-08-13FDA Approved: MYCOPHENOLATE MOFETIL — Supplemental Application (Lannett Company, Inc.)
FDA approved a supplemental application for mycophenolate mofetil from Lannett Company, authorizing a generic version under ANDA 214525.
-
FDA approval · 2024-08-13FDA Approved: MYCOPHENOLATE MOFETIL — Supplemental Application (CONCORD BIOTECH LIMITED)
FDA approved a supplemental application for mycophenolate mofetil from Concord Biotech Limited under ANDA 212087.
-
FDA approval · 2024-08-09FDA Approved: MYCOPHENOLATE MOFETIL — Supplemental Application (Accord Healthcare Inc.)
FDA approved a supplemental application for Accord Healthcare Inc.'s mycophenolate mofetil under an ANDA. The approval updates the generic p…
-
FDA approval · 2024-05-21FDA Approved: CYCLOSPORINE — Original Application (Devatis Inc.)
FDA approved Devatis Inc.'s cyclosporine as a generic drug under an original ANDA (ANDA209811).
-
FDA approval · 2024-02-20FDA Approved: MYCOPHENOLATE MOFETIL — Original Application (Aurobindo Pharma Limited)
FDA approved the original application for a generic version of mycophenolate mofetil (Aurobindo Pharma Limited) to prevent organ transplant …
-
FDA approval · 2024-01-25FDA Approved: TACROLIMUS — Original Application (Amneal Pharmaceuticals NY LLC)
FDA approved TACROLIMUS under Original Application from Amneal Pharmaceuticals NY LLC, including standard and extended-release capsule formu…
-
FDA approval · 2024-01-05FDA Approved: MYCOPHENOLATE MOFETIL — Original Application (Aurobindo Pharma Limited)
FDA approved the original application for mycophenolate mofetil from Aurobindo Pharma Limited, authorizing the generic immunosuppressant for…
-
FDA approval · 2024-01-03FDA Approved: MYCOPHENOLATE MOFETIL — Supplemental Application (Ascend Laboratories, LLC)
FDA approved Ascend Laboratories' supplemental application for mycophenolate mofetil (ANDA 091249).
-
FDA approval · 2023-11-29FDA Approved: MYCOPHENOLIC ACID — Original Application (Biocon Pharma Inc.)
FDA approved mycophenolic acid from Biocon Pharma Inc. via an original application. It is indicated to prevent organ transplant rejection in…